Free Trial

Insider Selling: Milestone Scientific Inc. (NYSE:MLSS) Major Shareholder Sells 26,855 Shares of Stock

Milestone Scientific logo with Medical background

Milestone Scientific Inc. (NYSE:MLSS - Get Free Report) major shareholder S.R.L. Bp4 sold 26,855 shares of Milestone Scientific stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $0.91, for a total transaction of $24,438.05. Following the transaction, the insider now directly owns 9,591,602 shares of the company's stock, valued at approximately $8,728,357.82. This trade represents a 0.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.

S.R.L. Bp4 also recently made the following trade(s):

  • On Friday, June 6th, S.R.L. Bp4 sold 60,200 shares of Milestone Scientific stock. The shares were sold at an average price of $0.90, for a total transaction of $54,180.00.
  • On Thursday, May 29th, S.R.L. Bp4 sold 3,361 shares of Milestone Scientific stock. The shares were sold at an average price of $0.96, for a total transaction of $3,226.56.
  • On Wednesday, May 28th, S.R.L. Bp4 sold 14,256 shares of Milestone Scientific stock. The stock was sold at an average price of $0.96, for a total transaction of $13,685.76.

Milestone Scientific Price Performance

MLSS stock traded down $0.01 during midday trading on Friday, reaching $0.88. The company had a trading volume of 60,574 shares, compared to its average volume of 129,701. Milestone Scientific Inc. has a 1-year low of $0.58 and a 1-year high of $1.39. The stock has a 50 day moving average price of $0.94 and a 200-day moving average price of $1.00. The company has a market capitalization of $69.06 million, a price-to-earnings ratio of -12.57 and a beta of 0.90.

Institutional Trading of Milestone Scientific

A number of institutional investors and hedge funds have recently made changes to their positions in MLSS. Renaissance Technologies LLC boosted its stake in shares of Milestone Scientific by 72.8% in the 4th quarter. Renaissance Technologies LLC now owns 126,275 shares of the company's stock valued at $121,000 after purchasing an additional 53,198 shares in the last quarter. XTX Topco Ltd grew its stake in shares of Milestone Scientific by 99.2% during the first quarter. XTX Topco Ltd now owns 34,135 shares of the company's stock worth $32,000 after buying an additional 17,002 shares during the last quarter. Finally, Brookwood Investment Group LLC acquired a new position in shares of Milestone Scientific during the first quarter worth $46,000. Institutional investors own 5.79% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen initiated coverage on shares of Milestone Scientific in a report on Sunday, May 18th. They issued a "hold" rating for the company.

Get Our Latest Research Report on Milestone Scientific

Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Featured Stories

Insider Buying and Selling by Quarter for Milestone Scientific (NYSE:MLSS)

Should You Invest $1,000 in Milestone Scientific Right Now?

Before you consider Milestone Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Milestone Scientific wasn't on the list.

While Milestone Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines